Latest Industry Insights

We spoke to Nadia Whittley, CEO, Arquer Diagnostics, to learn about some of the current limitations of diagnosing bladder and prostate cancer, and how MCM5-ELISA tests could help.

To find out more about the recent advancements in metabolomics, we spoke to Robin Fastenau from Metabolon, a company that specialises in these areas.

SCIEX have launched their new X500B QTOF Mass Spectrometry System. To find out more, and to see how the new system helps over come current problems in biophama, we spoke to Farzana Azam, Senior Director of Pharmaceutical Business at SCIEX.

Cecil Instruments have launched a new low-cost HPLC system, To find out more, and to see how this new instrument can help analysts, we spoke to Ade Kujore from Cecil Instruments.

Researchers have completed the most comprehensive analysis of the wheat genome to date, providing new hope for the improvement of this vital crop.

Synpromics are a leading developer of synthetic promoters in the field of biosynthetics. Founder and CSO Michael Roberts gives us an overview of the company and explains the importance of their new collaboration with GE Healthcare.

To learn about some of the challenges of extracting plasma from blood, and how a recently developed microfluidic device could help overcome some of these, we spoke to Dr. Weihua Li.

We spoke to Bruce Savage, CEO at GFC Diagnostics to learn more about the MicroScreen test.

To find out about the sbv IMPROVER project and its aims, we spoke to Dr Julia Hoeng, Director of Systems Toxicology at PMI Research & Development.

Find out about emerging trends in mass spectrometry from an industry expert.